On June 22, 2026, Serendia LLC filed a patent infringement complaint against InMode Ltd. and its subsidiary, Invasix Inc., in the U.S. District Court for the Central District of California. The lawsuit alleges infringement of four U.S. patents related to microneedling dermatological treatment devices, specifically Morpheus8 products and associated platforms. Serendia seeks unspecified damages and an injunction. Additionally, a parallel complaint was filed with the International Trade Commission seeking a limited exclusion order to bar importation and a cease-and-desist order for U.S. inventory. InMode intends to contest the claims and challenge the validity of the patents. The company cannot currently estimate a range of potential loss. InMode operates in the medical aesthetics industry, developing energy-based platforms for minimally invasive procedures.
